Severe rhabdomyolysis induced by bezafibrate in the treatment of severe acute pancreatitis with hyperlipidemia: A case report
In clinical practice, it is necessary to dynamically monitor the changes of liver and kidney functions and myocardial enzyme spectrum when using bezafibrate tablets to treat hyperlipidemic pancreatitis.
Authors
- De Su (ORCID: https://orcid.org/0000-0002-4050-8250)
- Zhengguang Geng
- Xiaoyun Fu (ORCID: https://orcid.org/0000-0003-1727-449X)
- Bao Fu (ORCID: https://orcid.org/0000-0002-6836-229X)
- Fei Gao (ORCID: https://orcid.org/0000-0002-1235-8005)
- Bao Zhang (ORCID: https://orcid.org/0000-0003-3015-8880)
- Chan Yang (ORCID: https://orcid.org/0000-0002-6727-8790)
- Hua Yao (ORCID: https://orcid.org/0009-0002-7942-6946)
Institutions
- Zunyi Medical University (CN)
- First People’s Hospital of Zunyi (CN)
Publication Details
- Journal
- Medicine
- Published
- 2025-06-27
- DOI
- https://doi.org/10.1097/md.0000000000043009
- Citations
- 1
- Primary Topic
- Muscle and Compartmental Disorders
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- National Natural Science Foundation of China